INVEST IN AMERICA WEEKLY ROUNDUP

  • Invest in America released two polls with Data for Progress: the first demonstrates that a broad majority of voters want Congress to raise the debt ceiling, while the second shows that an overwhelming majority of voters support the Build Back Better Act’s provisions to allow Medicare to negotiate drug prices and create the Clean Energy Performance Program. Key findings include:
    • 54% of voters, including 74% of Democrats and 54% of Independents, support the short-term government funding bill that raises the debt ceiling and prevents a government shutdown.

    • 73% of voters, including 83% of Democrats, 71% of Independents, and 65% of Republicans, support allowing Medicare to negotiate the cost of prescription drugs.

    • 58% of voters, including 79% of Democrats, 56% of Independents, and 35% of Republicans, support the Build Back Better agenda’s Clean Energy Performance Program.

  • Invest in America Action hosted a press conference in Arizona urging Arizona Senator Kyrsten Sinema to support the tax cuts for Arizona families that are included in the Build Back Better agenda, featuring Phoenix Councilwoman Betty Guardado, Executive Director of Children’s Action Alliance David Lujan, and CPA Jim Simpson. The speakers discussed the proven benefits of the Child Tax Credit, the need to make the Earned Income Tax Credit permanent, and requiring corporations and the wealthy to pay their fair share in taxes. View a recording here.

  • Invest in America Action released a new digital ad, “Economists Read GOP Tweets,” featuring renowned economists debunking false GOP talking points on inflation and explaining why the Build Back Better agenda is needed to create millions of good-paying jobs, ensure the economy works for everyone, and lower costs for the middle class.

  • Invest in America Action circulated a report explaining that widespread descriptions of the Build Back Better Act’s cost as $3.5 trillion are misleading, since the plan’s net cost is $0. The report noted that media reports tended to characterize Trump’s tax cuts by their net cost of $2 trillion, rather than using the gross cost figure of over $5 trillion.

  • Invest in America Action disseminated a fact sheet detailing Arizonans’ overwhelming support for the Build Back Better Act’s critical investments in child care, paid leave, affordable education, affordable housing, and clean energy.

  • Invest in America Action called out Republicans for putting American families at risk by blocking a bill to fund the United States government and lift the debt ceiling — despite voting to do so 10 times in the last 20 years — and noted the catastrophic effects that failing to raise the debt ceiling would have on American families and small businesses.

  • Invest in America highlighted data from the weekly unemployment report, noting that while jobless claims have trended downward since the passage of the American Rescue Plan, Americans are still eagerly awaiting the passage of both the Bipartisan Infrastructure Deal and the Build Back Better agenda to create millions of jobs and further strengthen the economy.

  • Invest in America Action amplified news reports that Senate Republicans’ move to block a bill that would fund the United States government and lift the debt ceiling pushed the United States closer to defaulting on its debt and placing middle-class Americans, as well as the entire economy at risk.

INVEST IN AMERICA COVERAGE

Common Dreams: ‘Eye-Popping Rip-Off’: Americans Pay Nearly Double Rest of World Combined for Top Meds

[…] A survey published Thursday by Invest in America and Data for Progress revealed that 73% of likely U.S. voters support allowing Medicare to negotiate the cost of prescription drugs.

However, Republican and some Democratic lawmakers have been fighting efforts to reduce prescription drug prices, and other reforms. For example, Sen. Kyrsten Sinema (D-Ariz.)—who campaigned on a promise to “lower prescription drug prices”— has been one of the staunchest congressional opponents of allowing Medicare to leverage its tremendous purchasing power to negotiate lower medication prices.

As Common Dreams reported Wednesday, members of Congress have been the leading beneficiaries of Big Pharma largesse, as drugmakers and private health insurers have spent $171 million so far in 2021 on lobbying—the most of any industry.

The Wall Street Journal: The Pandemic Prompts More Companies to Offer Paid Sick Time and Leave—but Millions of Workers Still Don’t Get It

[…] Current federal law provides no national paid leave, though nine U.S. states and Washington, D.C., have passed paid family medical-leave laws. According to the Center on Budget and Policy Priorities, a progressive think tank, only about a third of workers live in those states. The spending bill in Congress could mandate up to 12 weeks of paid leave for workers caring for new children or sick family members.

An April 2021 survey conducted by Invest in America and Data for Progress found that 75% of likely U.S. voters across political parties support a national paid family and medical leave policy, including 64% of Republicans and 91% of Democrats.

###